Elekta (OTCMKTS:EKTAY) Releases Quarterly Earnings Results

Elekta (OTCMKTS:EKTAY) announced its quarterly earnings data on Thursday. The company reported $0.07 earnings per share for the quarter, Zacks reports. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%.

Elekta Stock Down 3.0%

Shares of OTCMKTS EKTAY opened at $5.69 on Thursday. Elekta has a 52-week low of $4.35 and a 52-week high of $6.93. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.68 and a current ratio of 0.87. The stock has a market cap of $2.10 billion, a P/E ratio of -35.56 and a beta of 1.01. The firm has a 50 day moving average price of $5.18 and a 200 day moving average price of $5.71.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 28th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Elekta has an average rating of “Reduce”.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.